a company which engages in development of drugs to treat gastroenterological disorders and disease
Industry PharmaceuticalsOther
A.I.dvisor tells us that EVOK and SBFM have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVOK and SBFM's prices will move in lockstep.
Ticker / NAME | Correlation To EVOK | 1D Price Change % | ||
---|---|---|---|---|
EVOK | 100% | -3.61% | ||
SBFM - EVOK | 25% Poorly correlated | -0.35% | ||
CYTH - EVOK | 20% Poorly correlated | -4.11% | ||
DERM - EVOK | 12% Poorly correlated | -3.82% | ||
ITCI - EVOK | 11% Poorly correlated | -0.38% | ||
HCM - EVOK | 10% Poorly correlated | -0.06% | ||
More |
Ticker / NAME | Correlation To EVOK | 1D Price Change % |
---|---|---|
EVOK | 100% | -3.61% |
gastroenterological theme (2 stocks) | 79% Closely correlated | -0.38% |
drugs theme (265 stocks) | 8% Poorly correlated | +5.37% |
pharmaceuticals theme (167 stocks) | 4% Poorly correlated | +0.82% |
Pharmaceuticals: Other theme (252 stocks) | 4% Poorly correlated | +0.05% |
Pharmaceuticals theme (328 stocks) | 4% Poorly correlated | +0.11% |